Navigation Links
Cannabidiol "CBD" Strain of Medical Marijuana Establishing New CBD-Oil Nutraceutical Marketplace - Company Aims for Sales of CBD Products in all 50 States

CORAL SPRINGS, Florida, September 24, 2014 /PRNewswire/ --


Medical Marijuana and Cannabidiol (CBD Oils) gains momentum towards acceptance as viable medical treatment, significant clinical trial underway for possible seizure treatment and other CBD treatable ailments: Earth Science Tech, Inc. (OTC: ETST), GW Pharmaceuticals plc. (NASDAQ: GWPH), Cannabis Science, Inc. (OTC: CBIS), Easton Pharmaceuticals Inc. (OTC: EAPH) and Hemp, Inc. (OTC: HEMP)

Earth Science Tech, Inc. (OTCQB: ETST), a unique biotechnology company focused on nutraceuticals, bioceuticals and dietary supplements, announced today that its CEO, Harvey Katz PhD, as well as the company, was featured in a live video and article done by the Cannabis Financial Network. This new coverage and live CEO interview featured by Cannabis Financial Network outlines the recent success ETST has made in rapidly growing and expanding its business as an emerging company on many fronts. See the Full Live CEO Interview at

To Read the Full ETST press release, please go to:

ETST is happy to see that the Cannabis Financial Network has taken notice that ETST is an emerging company delivering cutting edge Nutraceuticals, Bioceuticals and Dietary Supplements designed for excellence in the areas of Health, Wellness, Sports and Alternative Medicine. This also includes that fact that ETST looks to help improve the quality of life for Consumers Worldwide through the use of such products. ETST is also dedicated to providing Natural Alternatives to prescription medications through Nutritional Supplements and Dietary Supplements that help improve common disorders and illnesses. To read the coverage and article featured by the Cannabis Financial Network on ETST go to

CBD Commentary from Cannabis Financial Network: CBD has even been shown to promote nutritional health in aging people, acting as an antioxidant and neuroprotectant, superbly suited to age-related inflammatory and autoimmune diseases. Pair the 10,000-plus Baby Boomers retiring per day (Pew Research) and Research and Markets' latest report on the U.S. nutraceutical market indicating a projected 6% CAGR through 2017, as the space swells to some $75.3B or more, and you get a perfect storm for CBD nutraceuticals.

One of the more compelling plays in the space today is Earth Science Tech, Inc. (OTCQB: ETST), which recently received its first two shipments of non-psychoactive, food-grade, CBD-enriched hemp oil, which is completely legal in 50 states and over 40 countries worldwide (as per U.S. Hemp Foods specifications). With over 50 liters from their first two shipments, an initial order already out the door to an outlet in Fort Lauderdale and management working hard to drum up additional supply lines, Earth Science Tech is rapidly moving towards widespread commercialization while setting themselves up to be a high-volume throughput channel for high-grade CBD. Perhaps more importantly, management is steadfastly committed to genuinely helping consumers get the best nutrition and dosing information possible, as well as creating shareholder upside. This was clearly demonstrated by the CEO in a recent video interview with leading cannabis investment news source, CannabisFN, when he said a salary won't be pursued until he knows the company is doing well.

GW Pharmaceuticals plc, (NASDAQ: GWPH) a biopharmaceutical company, together with its subsidiaries, is engaged in discovering, developing, and commercializing cannabinoid prescription medicines. The company operates through three segments: Sativex Commercial, Sativex Research and Development, and Pipeline Research and Development.  GW commercialized the world's first plant-derived cannabinoid prescription drug, Sativex(R), which is approved for the treatment of spasticity due to multiple sclerosis in 26 countries outside the United States. Sativex is also in Phase 3 clinical development as a potential treatment of pain associated with advanced cancer. This Phase 3 program has received Fast Track Designation from the U.S. Food and Drug Administration (FDA) and is intended to support the submission of a New Drug Application for Sativex in cancer pain with the FDA and in other markets around the world.

Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, recently announced the signing of a globally-exclusive, collaborative agreement with multinational company Unistraw Holdings Pte. Ltd. (Unistraw). The agreement provides for the immediate commencement of proprietary formulation to deliver cannabis and hemp extracts and pure cannabinoid-based products using the patented Unistraw Delivery System (UDS). With the successful outcome of effective formulations, Cannabis Science and Unistraw have agreed to form a joint venture to further refine, develop, and bring to market a variety of proprietary cannabis, hemp, and cannabinoid-based nutraceutical and pharmaceutical products. Concurrently, the Companies will share in the development of new intellectual property and novel advancements of the venture.

Easton Pharmaceuticals Inc. (OTC Pink: EAPH) announced an update on the mPact - GROzone Antimicrobial System through its investment and ownership interest in AMFIL Technologies.  Easton's partner AMFIL Technologies has updated the company and advised that the mPact - GROzone Antimicrobial Systems has received broad interest, is in discussions and has signed non disclosure agreements with the hopes to soon integrate other mPact - GROzone Antimicrobial Systems into a licensed large Canadian medical marijuana grow facility in Canada and into possibly another very large facility who has received a letter to build from Health Canada under the new MMPR system.

Resource Ventures, Inc. (OTC: REVI) Kimberly Kaiser, President of Resource Ventures, Inc, announced recently that the company, with the guidance of the consulting services of The Industrial Hemp and Medical Marijuana Consulting Company, Inc., IHMMCC, a wholly owned subsidiary of Hemp, Inc. (OTC Pink: HEMP), has elected to form a wholly-owned Multi-Media Subsidiary, which will include a broad range of media platforms from web-based sources to live and alternative broadcasts.  Mrs. Kaiser said, "We intend to fill the void between the Cannabis Industry and the general public when it comes to genuine, timely, and accurate information regarding cannabis news, legislation, and current events, we believe that with our publishing and media expertise we can successfully fulfill this void for information".  Mrs. Kaiser also stated that, "We see enormous potential to capture a large audience and successfully monetize the opportunity before us in the virtually untapped Cannabis Industry Media Sector. Mrs. Kaiser added, "We are very excited about the explosive growth that we are experiencing in 2014 and we look forward to continued growth into 2015." is leading provider of third party publishing & news dissemination services.  If you would like more information regarding our news coverage solutions, please visit for more details.  Get an edge on the market with our Premium News Alerts that are FREE for a limited time at  Follow us on Facebook: and Twitter: 

DISCLAIMER:  FN Media Group LLC (FNMG) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  FNMG is NOT affiliated in any manner with any company mentioned herein.  FNMG and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.  All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.  FNMG is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.  For current services performed FNMG has been compensated one thousand six hundred dollars for news coverage of the current press release issued by Earth Science Tech, Inc by the company.  FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE. 

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.

Contact Information:
Company:        FN Media Group, LLC
Contact email:
U.S. Phone:     +1(954)345-0611

SOURCE FN Media Group, LLC
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Life Technologies Develops Simplified SAME-DAY STEC Solution for Detecting Multiple Strains of E. coli in Ground Beef
2. Life Technologies Collaborates with USDA to Develop Same-Day, Multi-Strain E. coli Detection System
3. ImmBio Wins Funding from UK Government-Backed Biomedical Catalyst to Develop Multi-Strain Pneumococcal Vaccine
4. Though Vital to Educating Doctors on New Products, Pharma "Med Ed" Groups Working Under Huge Internal & External Constraints
5. Lakewood-Amedex Announces Its Novel Bisphosphocin Class Of Antimicrobials Are Active Against NDM-1 Positive Bacterial Strains
6. New Strains of Nevil and ReeferMan Medical Marijuana Seeds Now Available Online From R.M.S.S. Medical Marijuana Seed Sales
7. Seahorse Bioscience - Growing in a World of Budget Constraints
8. Novel Molecular Assay for Patient Screening Detects S. aureus and Newly Emerging MRSA Strains Available in the United States
9. Cannabis Science Initiates Scientific Cultivation Programs to Test Multiple Strains of Cannabis to Obtain Extract Formulations for Clinical Drug Development Targeting Multiple Critical Ailments Starting with Cancer and Neurological Disorders
10. China BioPharmaceutical Industry - Cutting-Edge Analysis of Multinational and Chinese Pharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges
11. Interviewed Payers in the EU5 Anticipate Increasing Prescribing Constraints for Premium-Priced Type 2 Diabetes Agents
Post Your Comments:
(Date:5/30/2020)... ... ..., the official parenting website of the American Academy of Pediatrics (AAP), ... winners will receive a $200* gift card. The contest begins June 15 and ... during the event. Winners will be drawn on or about June 22, 2020. Full ...
(Date:5/28/2020)... ... ... When Sean Fitzgerald was in business leadership for a national in-home care franchise, ... services needed to keep older adults in their homes, but it was hard to ... be in a position to help provide those property maintenance and repair services as ...
(Date:5/28/2020)... ... May 28, 2020 , ... This new ... , “ is an acknowledgement-based notification platform,” said Bob Lueth, President of ... PUSH notification, SMS text message, Email or Voice phone call—will be tracked by ...
Breaking Medicine Technology:
(Date:5/25/2020)... , ... May 23, 2020 , ... Winemaker Grant Long ... We wanted to present something whimsical and delicious in these complicated times,” he said, ... Blend ($34.99) and 2018 Grenache ($24.99). The Chardonnay and Red Wine Blend are sourced ...
(Date:5/21/2020)... ... May 21, 2020 , ... ... industry leader in cancer biomarker assays, announced today that Cigna has added ROMA® ... is a global health service company dedicated to improving the health, well-being, and ...
(Date:5/21/2020)... ... May 21, 2020 , ... ... Home Order” will be lifted on May 28th and all businesses will be ... local companies returning back to work. , As an essential business, AmeriCare Medical ...
(Date:5/21/2020)... ... May 21, 2020 , ... A new report ... Group, details over 90 companies involved in the point of care test industry. ... for preliminary testing, COVID-19 has made point-of-care more important than in the past, according ...
(Date:5/16/2020)... ... May 15, 2020 , ... On May 21, T1V will host a webinar featuring Dr. ... USC, and a contributor to CBS news, as we address COVID-19 and the impact on ... parts of the country since March, many questions are left unanswered as we look at ...
Breaking Medicine News(10 mins):